RPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Royalty Pharma plc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$60.27−0.69 (-1.13%)
Close on Oct 19, 2026
- Market cap
- $33.56B
- P/E (TTM)
- 34.2
- Dividend yield
- –
Dividends
Dividend declared per share by fiscal year, adjusted for stock splits
Per share, FY2025
–
Consecutive increases
0 years
Not raised last year
Five-year growth
–
Per year, per share
Payout ratio, FY2025
–
Dividends paid ÷ net income
Dividend history
By fiscal year
| Fiscal year | Per share | Change | Cash paid | Payout ratio |
|---|---|---|---|---|
| FY2025 | – | – | – | – |
| FY2024 | $0.84 | +5.0% | – | – |
| FY2023 | $0.80 | +5.3% | – | – |
| FY2022 | $0.76 | +11.8% | – | – |
| FY2021 | $0.68 | +126.7% | – | – |
| FY2020 | $0.30 | – | – | – |
Ex-dividend and payment dates for each distribution will appear once a dividend calendar source is connected.